Katherine Lorraine Grady, MSW, CAPSW | |
845 Parkside St, Ripon, WI 54971-8505 | |
(920) 926-4200 | |
(920) 926-8933 |
Full Name | Katherine Lorraine Grady |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 11 Years |
Location | 845 Parkside St, Ripon, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760046981 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 9339-123 (Wisconsin) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Agnesian Healthcare Inc | 1658289624 | 319 |
News Archive
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.
Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.
ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.
› Verified 1 days ago
Entity Name | Agnesian Healthcare Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.
Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.
ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.
› Verified 1 days ago
Entity Name | Waupun Memorial Hospital |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1548248644 PECOS PAC ID: 7618886565 Enrollment ID: O20070523000593 |
News Archive
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.
Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.
ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Katherine Lorraine Grady, MSW, CAPSW 620 W Brown St, Waupun, WI 53963-1702 Ph: () - | Katherine Lorraine Grady, MSW, CAPSW 845 Parkside St, Ripon, WI 54971-8505 Ph: (920) 926-4200 |
News Archive
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin.
Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.
ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
RaySearch Laboratories: JANUARY 1 - SEPTEMBER 30, 2011. Net sales for the period totaled SEK 80.3 M.
› Verified 1 days ago
Laurie Ann Rechek, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 845 Parkside St, Ripon, WI 54971 Phone: 920-926-4200 Fax: 920-926-8914 | |
Sarah Ann Heyn, MSSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 723 Chester Court, Ripon, WI 54971 Phone: 217-235-3877 Fax: 803-356-8580 | |
Racheal Anne Pluim-bergmann, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 835 Parkside St, Ripon, WI 54971 Phone: 920-748-3101 |